| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/10/2013 | US20130012456 Compositions and methods for transport across the blood brain barrier |
| 01/10/2013 | US20130012455 Use of ARC for inhibiting cell death during liver failure |
| 01/10/2013 | US20130012451 Compositions and methods for inhibiting mmp-9-mediated cell migration |
| 01/10/2013 | US20130012437 Lytic peptides having anti-proliferative activity against prostate cancer cells |
| 01/10/2013 | US20130012413 In vitro assays for enriching and determining the clonogenic potential of stem cells |
| 01/10/2013 | US20130012405 Circulating miRNA Biomaker Signatures |
| 01/10/2013 | US20130012404 Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
| 01/10/2013 | US20130011924 Method for inducing differentiation of pluripotent stem cells into mesodermal cells |
| 01/10/2013 | US20130011923 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130011922 Nucleic acid compounds for inhibiting gene expression and uses thereof |
| 01/10/2013 | US20130011921 Method for production of artificial pluripotent stem cell |
| 01/10/2013 | US20130011920 Methods for Reducing Protein Levels in a Cell |
| 01/10/2013 | US20130011919 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof |
| 01/10/2013 | US20130011918 Methods for telomere length and genomic dna quality control and analysis in pluripotent stem cells |
| 01/10/2013 | US20130011917 Method of generating myelinating oligodendrocytes |
| 01/10/2013 | US20130011903 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 01/10/2013 | US20130011901 Cyclic compound, method for producing cyclic compound, and method for modifying biological molecule |
| 01/10/2013 | US20130011878 Antigen binding proteins that bind par-2 |
| 01/10/2013 | US20130011869 Novel monoclonal antibodies and method of immunological analysis of d-dimer |
| 01/10/2013 | US20130011825 Methods and systems for reducing dna fragmentation in a processed sperm sample |
| 01/10/2013 | US20130011487 Fluorinated block co-polymers |
| 01/10/2013 | US20130011448 System for improved delivery of gene modulating compounds |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011427 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 01/10/2013 | US20130011426 Recombinant Vaccines and Use Thereof |
| 01/10/2013 | US20130011418 Antibody-Drug Conjugates |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011406 Anti-kit antibodies and uses thereof |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011403 Klebsiella antigens |
| 01/10/2013 | US20130011402 Compositions and methods for the diagnosis and treatment of tumor |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011394 Complexes comprising mhc class i fusion polypeptides and antigen-specific antibodies and methods of use |
| 01/10/2013 | US20130011380 Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming |
| 01/10/2013 | US20130011376 Methods for Enhancing Natural Killer Cell Proliferation and Activity |
| 01/10/2013 | US20130011375 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 01/10/2013 | US20130011373 Side population cells in cardiac repair |
| 01/10/2013 | US20130011372 Inactivated microorganisms containing double -strand rna molecules (dsrna), their use as pesticides and methods for their preparation |
| 01/10/2013 | US20130011371 ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) |
| 01/10/2013 | US20130011338 Cupredoxin derived transport agents and methods of use thereof |
| 01/10/2013 | US20130011335 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and SRC |
| 01/10/2013 | US20130011333 Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery |
| 01/10/2013 | CA2852053A1 Enzymes that synthesize zingiberene |
| 01/10/2013 | CA2844532A1 An antibody inducing antigen-specific t cell tolerance and use thereof |
| 01/10/2013 | CA2841372A1 Agr2 blocking antibody and use thereof |
| 01/10/2013 | CA2840424A1 Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders |
| 01/10/2013 | CA2840307A1 Progenitor cells of mesodermal lineage |
| 01/10/2013 | CA2840162A1 Constitutively active aba receptor mutants |
| 01/10/2013 | CA2839651A1 Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
| 01/10/2013 | CA2839341A1 Methods of treating or preventing rheumatic disease |
| 01/10/2013 | CA2839106A1 A treatment method for mesenchymal stem cells and their application as a treatment of oxidative stress related diseases |
| 01/10/2013 | CA2838964A1 Albumin formulation and use |
| 01/10/2013 | CA2838819A1 Methods for predicting mammalian embryo viability |
| 01/10/2013 | CA2838695A1 Mammalian cell culture |
| 01/09/2013 | EP2543727A1 Modified antibody composition |
| 01/09/2013 | EP2543719A1 Meander bioreactor and method for dynamic expansion, differentiation and harvest of hematopoietic cells |
| 01/09/2013 | EP2543380A1 Neural stem cells proliferation promoting agent |
| 01/09/2013 | EP2542671A2 Microbial engineering for the production of fatty acids and fatty acid derivatives |
| 01/09/2013 | EP2542670A2 Induced dendritic cell compositions and uses thereof |
| 01/09/2013 | EP2542669A1 Ets2 and mesp1 generate cardiac progenitors from fibroblasts |
| 01/09/2013 | EP2542668A2 Tissue for prosthetic implants and grafts, and methods associated therewith |
| 01/09/2013 | EP2542667A2 Methods for purifying cells derived from pluripotent stem cells |
| 01/09/2013 | EP2542666A1 Culture additives to boost stem cell proliferation and differentiation response |
| 01/09/2013 | EP2542663A1 Circulation system |
| 01/09/2013 | EP2542184A2 Percutaneously deliverable heart valve and methods associated therewith |
| 01/09/2013 | EP2542047A2 Compositions and methods for increasing biomass, iron concentration, and tolerance to pathogens in plants |
| 01/09/2013 | EP1452150B1 Chemical cleaning of biological material |
| 01/09/2013 | CN102869988A Method for evaluating graft |
| 01/09/2013 | CN102869823A Sheet-like fiber structure, and battery, heat insulation material, waterproof sheet and scaffold for cell culture, each using the sheet-like fiber structure |
| 01/09/2013 | CN102869768A Microbial engineering for the production of fatty acids and fatty acid derivatives |
| 01/09/2013 | CN102869762A Method of reseeding adherent cells grown in a hollow fiber bioreactor system |
| 01/09/2013 | CN102869682A Monoclonal antibodies and diagnostic uses thereof |
| 01/09/2013 | CN102869391A Engineered biological nerve graft fabrication and application thereof |
| 01/09/2013 | CN102869320A Percutaneously deliverable heart valve and methods associated therewith |
| 01/09/2013 | CN102864146A Application of ath-eTM160 in inhibiting functions of microRNA160 |
| 01/09/2013 | CN102864145A Efficient inducible expression promoter and application |
| 01/09/2013 | CN102864125A Method for preparing monoclonal hybrid tumors |
| 01/09/2013 | CN102864124A Renal-source stem/progenitor cell for expressing nestin |
| 01/09/2013 | CN102864123A Acquisition method of peripheral blood mesenchymal stem cells and application thereof |
| 01/09/2013 | CN102864122A Equine embryo-flushing solution as well as preparation method and applications of solution |
| 01/09/2013 | CN102864121A Model for quickly screening lipid-lowering drugs by adipose cell/hepatic cell co-culture model and application of model for quickly screening lipid-lowering drugs |
| 01/09/2013 | CN102864120A Suspension culture method of embryo cells of sweet potatoes and embryo cells obtained by method |
| 01/09/2013 | CN102864119A Carrier for cell culturing and preparation method of carrier |
| 01/09/2013 | CN102864118A Water-soluble collagen with anti-crosslinking function |
| 01/09/2013 | CN102863536A Fusion protein GPR85-Gilalpha, its coding gene and application |
| 01/09/2013 | CN102863535A Fusion protein GPR45-Gilalpha, its coding gene and application |
| 01/09/2013 | CN102863534A Fusion protein GPR174-Gilalpha, its coding gene and application |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863523A Vegetable yellow dwarf resistant key protein TiRB and coding gene and application thereof |
| 01/09/2013 | CN102863520A Recombinant protein comprising starch binding domain and use thereof |
| 01/09/2013 | CN102863515A B-cell epitope of human melanoma antigen MAGE-A3 and application thereof |
| 01/09/2013 | CN102863514A Peptide vaccines for cancers expressing tumor-associated antigens |
| 01/09/2013 | CN102861359A Decellularization and recellularization of organs and tissues |
| 01/09/2013 | CN102861107A DC-CIK (dendritic cells-cytokine-induced killers) cell treatment composition |
| 01/09/2013 | CN102861103A Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure |
| 01/09/2013 | CN102433306B Cell strain from pleomorphic human lung carcinomas and preparation method thereof |
| 01/09/2013 | CN102424816B Cell line derived from recurrent lesions after human small cell lung cancer radiotherapy and chemotherapy, and preparation method thereof |
| 01/09/2013 | CN102250844B Protein associated with synthesis of carotenoid as well as encoding gene and application thereof |
| 01/09/2013 | CN102212529B Gene for controlling seed size and grease synthesis |